CPhI South East Asia Brings Spotlight on Indonesia
The event will take place at the Jakarta International Expo, Indonesia from April 8–10, 2015.
CPhI South East Asia will take place at the Jakarta International Expo, Indonesia from April 8–10, 2015. Organized by UBM EMEA, the event provides a networking platform for domestic and international buyers and suppliers from the pharmaceutical industry.
Indonesia, which is believed to be the central hub for pharmaceuticals in South East Asia, has caught the attention of overseas companies looking to capitalize on this growing industry. In 2014, CPhI South East Asia attracted 240 exhibitors and more than 6000 visitors. This year, a total of 38 countries, including the United States, India, China, and Japan, will be represented at the show compared with 23 in 2014.
The Indonesian pharmaceutical market was valued at $6.5 billion in 2014. The sector is maintaining an annual growth rate of 12.5% until 2018 and the local government is implementing initiatives to increase drug demand. Indonesia holds a growth opportunity for both domestic and foreign companies and CPhI South East Asia serves as a platform for business opportunities to be started or fostered across the region.
Source: CPhI South East Asia
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
